# Effects of Second-generation Antihistamine Bepotastine on Cough Outcomes in Cough Patients With Allergic Rhinitis

> **NCT04877678** · PHASE4 · COMPLETED · sponsor: **Asan Medical Center** · enrollment: 50 (actual)

## Conditions studied

- Allergic Rhinitis
- Cough

## Interventions

- **DRUG:** Bepotastine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04877678
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-01
- **Primary completion:** 2022-09-01
- **Final completion:** 2022-10-31
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04877678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04877678, "Effects of Second-generation Antihistamine Bepotastine on Cough Outcomes in Cough Patients With Allergic Rhinitis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04877678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*